Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancer

International Journal of Gynecological Cancer

Volumn 18, Issue 5, 2008, Pages 1027-1031

  Lee, K B ^a   Lee, J M ^b   Ki, K D ^b   Lee, S K ^b   Park, C Y ^a   Ha, S Y ^a  

^a Gachon University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Adjuvant chemotherapy; Factors; Recurrence; Risk; Uterine cervical cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 51749119900     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01136.x     Document Type: Article

References (22)

1. Sedlis A, Bundy BN, Rotman MZ et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999 73 : 177 83.
2. Lai CH, Lin TS, Soong YK, Chen HF. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989 35 : 193 8.
3. Curtin JP, Hoskins WJ, Venkatraman ES et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol 1996 61 : 3 10.
4. Samlal RA, van der Velden J. Early cervical carcinoma: how to manage high-risk patients after radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 1999 85 : 137 9.
5. Peters WA III., Liu PY, Barrett RJ II. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000 18 : 1606 13.
6. NCCN Clinical Practice Guidelines in Oncology. Cervical cancer Version 1. 2007. Available at : http://www.nccn.org. Accessed June 1, 2007.
7. Delgado G, Bundy B, Zaino R et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990 38 : 352 7.
8. Chung CK, Nahhas WA, Stryker JA et al. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980 138 : 550 6.
9. Boyce J, Fruchter RG, Nicastri AD et al. Prognostic factors in stage I carcinoma of the cervix. Gynecol Oncol 1981 12 : 154 65.
10. Iwasaka T, Kamura T, Yokoyama M et al. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy. Obstet Gynecol 1998 91 : 977 81.
11. Hogan WM, Littman P, Griner L, Miller CL, Mikuta JJ. Results of radiation therapy given after radical hysterectomy. Cancer 1982 49 : 1278 85.
12. Russell AH, Tong DY, Figge DC, Tamimi HK, Greer BE, Elder SJ. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomy. Int J Radiat Oncol Biol Phys 1984 10 : 211 4.
13. Takeshima N, Umayahara K, Fujiwara K et al. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer. Gynecol Oncol 2006 103 : 618 22.
14. Lahousen M, Haas J, Pickel H et al. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecol Oncol 1999 73 : 196 201.
15. Monk BJ, Wang J, Im S et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005 96 : 721 8.
16. Thomas GM, Dembo AJ. Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer? Int J Gynecol Cancer 1991 1 : 1 8.
17. Soisson AP, Soper JT, Clarke-Pearson DL et al. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 1990 37 : 390 5.
18. Kinney WK, Alvarez RD, Reid GC et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol 1989 34 : 258 62.
19. Uno T, Ito H, Itami J et al. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. Anticancer Res 2000 20 : 2235 9.
20. Morrow CP, Shingleton HM, Austin JM et al. Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 1980 10 : 105 10.
21. Lee KB, Lee JM, Park CY et al. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study. Int J Gynecol Cancer 2006 16 : 1569 73.
22. Hockel M, Horn LC, Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol 2005 6 : 751 6.